Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • The saintly stocks versus the sinners: which ones perform the best?
    • Opinion

    The saintly stocks versus the sinners: which ones perform the best?

    In a new era in which environmental, social and governance (ESG) considerations have been enshrined in the way fundies pick their shares, the so-called ‘sin’ stocks had been largely discounted as relics of the past. Until Woolworths’ spin-off Endeavour Group (EDV) came along, that is. By virtue of Endeavour’s sheer size and pure-play focus on

    Read More
    Public
  • Bionomics granted Fast Track approval from FDA to study PTSD drug
    • News

    Bionomics granted Fast Track approval from FDA to study PTSD drug

    Once upon a time, stress ensured our survival. When faced with a dangerous situation our body responds instantly- heart rate increases, blood pressure climbs and muscles tighten as the body prepares to deal with the bear/ exam you’ve been presented with.  In the modern world we are faced with a disproportionately higher amount of exams

    Read More
    Public
  • Australian First – Carnarvon launches venture to produce renewable diesel and graphene
    • News

    Australian First – Carnarvon launches venture to produce renewable diesel and graphene

    Fresh off their declaration to be a net-zero carbon emissions business before 2050, oil and gas company Carnarvon Petroleum (ASX: CVN) has committed $2.6 million into a joint venture project aiming to produce renewable diesel and other sustainable products, including graphene. The fund will secure a 50% equity stake in the venue in partnership with

    Read More
    Public
  • ResApp study data published, further confirms app’s efficacy
    • News

    ResApp study data published, further confirms app’s efficacy

    Confirming the efficacy and broader potential of their smartphone-based diagnostic app, ResApp Health Limited (ASX: RAP) clinical data referenced in a top academic publication has validated their app’s accuracy for respiratory diagnostics. Data from their Breathe Easy adult clinical study has been published in a peer-reviewed Nature partner journal, npj Digital Medicine. The study looked

    Read More
    Public
  • Healthia expands in Queensland and Tasmania with attractive clinic acquisitions
    • News

    Healthia expands in Queensland and Tasmania with attractive clinic acquisitions

    It hasn’t taken long for allied healthcare operator Healthia (ASX: HLA) to get the ball rolling in the new financial year, acquiring three new businesses in Queensland and Tasmania under their annual commitment to deploy $20m towards growth each year.  The acquisitions include two optometry businesses in North Queensland and one physiotherapy clinic in Tasmania.

    Read More
    Public
  • Trading 101: Top tips for new traders
    • Opinion

    Trading 101: Top tips for new traders

    If you enjoy being actively involved in your investments, you may be interested in trading. Traders take advantage of small price movements to turn a profit. Starting on the right track is about understanding both the fundamentals of trading, and you as a trader. The best investment you can make is in your education. Do

    Read More
    Public
  • «
  • ‹
  • 485
  • 486
  • 487
  • 488
  • 489
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.